Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-8

A tale of three labels: translating the JUPITER trial data into regulatory claims

Paul M Ridker

Clinical Trials

Retricted access

Research article

First published 2015-4

Complete blood count risk score and its components,including RDW,are associated with mortality in the JUPITER trial

Benjamin D Horne, Jeffrey L Anderson, Joseph B Muhlestein [...]

European Journal of Preventive Cardiology

Retricted access

Research article

First published 2009-6

Are We All Hypo-Statinaemics?

P. Amarenco

International Journal of Stroke

Retricted access

Research article

First published 2008-8

Rosuvastatin and Cardiovascular Disease: Did the Strongest Statin Hold the Initial Promises?

Apostolos Efthimiadis

Angiology

Open access

Review article

First published 2012

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia

Ahmed Abbas, John Milles, Sudarshan Ramachandran

Clinical Medicine Insights: Endocrinology and Diabetes

Open access

Research article

First published 2018-3

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study

Jelena Pavlović, Philip Greenland, Jaap W Deckers [...]

European Journal of Preventive Cardiology

Free access

Review article

First published 2009-08

The Jupiter study,CRP screening,and aggressive statin therapy-implications for the primary prevention of cardiovascular disease

Richard Kones

Therapeutic Advances in Cardiovascular Disease

Search results

A tale of three labels: translating the JUPITER trial data into regulatory claims

Complete blood count risk score and its components,including RDW,are associated with mortality in the JUPITER trial

Are We All Hypo-Statinaemics?

Rosuvastatin and Cardiovascular Disease: Did the Strongest Statin Hold the Initial Promises?

Rosuvastatin and Atorvastatin: Comparative Effects on Glucose Metabolism in Non-Diabetic Patients with Dyslipidaemia

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study

The Jupiter study,CRP screening,and aggressive statin therapy-implications for the primary prevention of cardiovascular disease